(S)-5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(3,4-DIMETHOXYPHENYL)-METHYLAMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL
Compound with spectra: 1 NMR
![(S)-5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(3,4-DIMETHOXYPHENYL)-METHYLAMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL](/api/compound/6OaitorkU2L.png?ph=true&h=300&w=458 "(S)-5-CHLORO-ALPHA-(CYCLOPROPYLETHYNYL)-2-[(3,4-DIMETHOXYPHENYL)-METHYLAMINO]-ALPHA-(TRIFLUOROMETHYL)-BENZENEMETHANOL")
| SpectraBase Compound ID | 6OaitorkU2L |
|---|---|
| InChI | InChI=1S/C22H21ClF3NO3/c1-29-19-8-5-15(11-20(19)30-2)13-27-18-7-6-16(23)12-17(18)21(28,22(24,25)26)10-9-14-3-4-14/h5-8,11-12,14,27-28H,3-4,13H2,1-2H3/t21-/m0/s1 |
| InChIKey | NTOWNZYEUZOMLP-NRFANRHFSA-N |
| Mol Weight | 439.86 g/mol |
| Molecular Formula | C22H21ClF3NO3 |
| Exact Mass | 439.116206 g/mol |
| Enantiomer InChIKey | NTOWNZYEUZOMLP-OAQYLSRUSA-N |
| Racemate InChIKey | NTOWNZYEUZOMLP-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3,4-Dimethoxybenzyl)[2-methyl-5-(3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)phenyl]amine
2-[(3,4-dimethoxyphenyl)methylamino]-N-(3,3,7-trimethyl-2-oxidanylidene-1H-indol-5-yl)ethanamide
N-{2-[3-(o-METHOXYPHENYL)PROPYL]-1,2,3,4-TETRAHYDRO-5-ISOQUINOLYL}VERATRAMIDE
N-[1-[2-(2-chloroethyl)-4,5-dimethoxy-phenyl]-2-(3,4-dimethoxyphenyl)ethyl]acetamide
6,8-BIS(ALPHA-HYDROXYHEXAFLUOROISOPROPYL)-1,2,3,4-TETRAHYDROQUINOLINE
N-(4-ethoxy-3-methoxybenzyl)-2-(4-methoxyphenyl)-5-nitro-2H-1,2,3-triazol-4-amine 3-oxide
N-{2-[3-(o-methoxyphenyl)propyl]-1,2,3,4-tetrahydro-5-isoquinolyl}-3,4,5-trimethoxybenzamide
10-(3,4-Dimethoxybenzyl)-10H-acridin-9-one
3-Hydroxy-1-methyl-3-(7-(trimethylsilyl)hepta-1,6-diynyl)indolin-2-one
3-(Hepta-1,6-diynyl)-3-hydroxy-1-methylindolin-2-one
| Title | Journal or Book | Year |
|---|---|---|
| Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor | The Journal of Organic Chemistry | 1998 |